Identifying Improvements in an ED Elder Friendly Area Based on Patient Experience (EDEFA_TheirVoice Project)

NCT ID: NCT03717324

Last Updated: 2018-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-20

Study Completion Date

2019-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analyze patient experience of elders admitted to the Emergency Department Elder Friendly Area (EFA) and determine possible improvement options and potential solutions.

The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Method: This is a qualitative and quantitative evaluation project. The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families. Design Thinking is a creativity and innovation methodology that compiles tools based on design principles for problem solving. It is characterized by having the ability to mix convergent and divergent thinking, reconciling rational and intuitive thinking. This methodology consists of 4 phases: Mapping, Exploring, Building and Testing. In each of them, the tools and techniques help us to observe, get involved and immerse ourselves in the patient's ecosystem, with the aim of designing a solution WITH the user and not just FOR him. Consequently, the error is reduced and the modifications and improvements of our projects are speeded up.

Patients: Patients/caregivers attended in the Emergency Department's EFA will participate . In the first fieldwork, 50-60 patients will participate, conducting a self-completed interview (prior informed consent, 10 minutes long).

In the qualitative research phase, 5-10 patients/caregivers conduct a 30-minute interview with the Design Thinking professional. The co-creation workshop lasts a couple of hours and 5 to 10 patients/caregivers will participate. In the second fieldwork another 50-60 patients will participate. In total, between 110 and 140 patients will be enrolled.

Ethics: Patients/caregivers will be provided with a patient information sheet and informed consent prior to participation. Patient experience data will be collected by Design Thinking professional on an anonymous basis and will always be handled on an aggregate basis.

Funding: The project will be developed in collaboration with Merck Sharp \& Dohme Spain, with which there is an agreement signed (Fundació de Gestió HSCSP - MSD). For the correct development of it, MSD has hired a company expert in the development of this type of dynamics (Thinkers\&Co) which will participate actively in all meetings and workshops and will be responsible for collecting the opinion of the patient anonymously and manage this information in an aggregate way, always with the intention of identifying the points of improvement on which later health professionals will work with the methodology described. However, no monetary payment will be made to the hospital, to the emergency department or to the professionals involved. The collaboration of MSD and Thinkers\&Co will not affect the independent nature of the project.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergencies Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

First evaluation group (survey_1)

Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA)

No interventions assigned to this group

Co-creation group

Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA) who want to participate in the co-creation workshop

Procedure created in co-creation group

Intervention Type OTHER

Interventions will be those obtained from the co-creation workshop with patients

Second evaluation group (survey_2)

Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA), after improvements are made

Procedure created in co-creation group

Intervention Type OTHER

Interventions will be those obtained from the co-creation workshop with patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Procedure created in co-creation group

Interventions will be those obtained from the co-creation workshop with patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients attended in elder friendly area who agree to participate and their caregivers

Exclusion Criteria

* None
Minimum Eligible Age

65 Years

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mireia Puig

Role: PRINCIPAL_INVESTIGATOR

Hospital de la Santa Creu i Sant Pau, Emergency Department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mireia Puig, PhD

Role: CONTACT

+34616335291

Mireia Puig

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mireia Puig, PhD

Role: primary

+34616335291

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IIBSP-EXP-2018-80

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.